In this study, we investigated the effects of the local anesthetic n-butyl-p-aminobenzoate (BAB) on the delayed rectifier potassium current of cultured dorsal root ganglion (DRG) neurons using the patch-clamp technique. The majority of the K ϩ current of small DRG neurons rapidly activates and slowly inactivates at depolarized voltages. BAB inhibited the whole-cell K ϩ current of these neurons with an IC 50 value of 228 M. Dendrotoxin K (DTX K ), a specific inhibitor of Kv1
ϩ current of these neurons with an IC 50 value of 228 M. Dendrotoxin K (DTX K ), a specific inhibitor of Kv1.1, reduced the DRG K ϩ current at ϩ20 mV by 34%, consistent with an important contribution of channels incorporating the Kv1.1 subunit to the delayed rectifier current. To further investigate the mechanism of BAB inhibition, we examined its effect on Kv1.1 channels heterologously expressed in mammalian tsA201 cells. BAB inhibits the Kv1.1 channels with an IC 50 value of 238 M, similar to what was observed for the native DRG current. BAB accelerates the opening and closing of Kv1.1, but does not alter the midpoint of steady-state activation. BAB seems to inhibit Kv1.1 by stabilizing closed conformations of the channel. Coexpression with the Kv␤1 subunit induces rapid inactivation and reduces the BAB sensitivity of Kv1.1. Comparison of the heterologously expressed Kv1.1 and native DRG currents indicates that the Kv␤1 subunit does not modulate the gating of the DTX K -sensitive Kv1.1 channels of DRG neurons. Inhibition of the delayed rectifier current of these neurons may contribute to the long-duration anesthesia attained during the epidural administration of BAB.
Epidural administration of local anesthetics is a widely used technique for achieving short-term regional anesthesia. A promising new approach for the management of chronic pain is the epidural administration of sustained release formulations of local anesthetics. For example, epidural injections of the local anesthetic n-butyl-p-aminobenzoate (BAB) have proved to be effective in treating the intractable pain associated with advanced stages of cancer (Korsten et al., 1991; Shulman et al., 1998) . A single epidural treatment with BAB can effectively relieve chronic pain for prolonged intervals (Ͼ30 days) . Surprisingly, the pain relief produced by BAB is not associated with any demonstrable loss of motor function, suggesting that BAB selectively targets the nociceptive nerve fibers of the dorsal root (Korsten et al., 1991; Shulman et al., 1998; McCarthy et al., 2002) . Because BAB is hydrophobic and uncharged at physiological pH, it partitions into lipid bilayers but does not effectively distribute into the systemic circulation (Shulman et al., 1998; Kuroda et al., 2000) . The analgesia produced by BAB is highly localized with no detectable anesthesia in adjacent spinal segments (Korsten et al., 1991; Grouls et al., 2000) . The absence of significant side effects coupled with the long-duration anesthesia provides considerable support for the use of BAB formulations in the treatment of chronic pain.
The mechanism of BAB anesthesia and the origin of its highly selective block of nociception is not known. Studies of the mechanisms of BAB anesthesia have focused on small dorsal root ganglion (DRG) neurons as the most likely site of BAB action. In patch-clamp studies, BAB was found to inhibit the voltage-gated sodium currents of these neurons (Van den Berg et al., 1995 , which are believed to include the cell bodies of pain fibers (cf. Harper and Lawson, 1985) . Small DRG neurons express several distinct components of Na ϩ current that differ in gating kinetics and sensitivity to tetrodotoxin (TTX) (Kostyuk et al., 1981; Roy and Narahashi, 1992) . The TTX-sensitive and TTX-resistant Na ϩ currents of cultured DRG neurons display considerable dif-ferences in sensitivity to BAB (Van den Berg et al., 1995 . The inhibition of DRG Na ϩ currents is likely to contribute to the BAB anesthesia.
By comparison, the role of K ϩ channels in peripheral nerve anesthesia has not been extensively investigated. In large part, this reflects our rather sparse understanding of the K ϩ channels that are expressed in peripheral nerves and their role in the electrical excitability of these neurons. A variable combination of rapidly inactivating A-type (I A ) and slowly or noninactivating (I K ) K ϩ currents are observed in most DRG neurons (Kostyuk et al., 1981; Akins and McCleskey, 1993; Gold et al., 1996) . Pharmacological studies suggest that the I A and I K components of DRG K ϩ current can be further subdivided into several distinct components (Safronov et al., 1996) . Current estimates suggest that as many as six different channels may contribute to the outward K ϩ current in these neurons (Gold et al., 1996) . Dendrotoxin, a selective inhibitor of Kv1 channels (Harvey, 2001) , induces repetitive action potential firing of sensory neurons by selectively inhibiting the delayed rectifier current (Penner et al., 1986; Stansfeld et al., 1986 Stansfeld et al., , 1987 Hall et al., 1994; McAlexander and Undem, 2000; Glazebrook et al., 2002) . The message encoding for Kv1.1 is present in the DRG (Beckh and Pongs, 1990; Glazebrook et al., 2002) and immunocytochemistry indicates that Kv1.1 channels are expressed in small DRG neurons (Hallows and Tempel, 1998; Ishikawa et al., 1999; Glazebrook et al., 2002) . In addition, Kv1.1 knockout mice display hyperalgesia, consistent with an important role for these channels in nociception (Clark and Tempel, 1998) .
In this study, we found that BAB produces a concentrationdependent inhibition of the whole-cell K ϩ current of cultured DRG neurons. Dendrotoxin K (DTX K ), a specific inhibitor of channels incorporating the Kv1.1 subunit (Robertson et al., 1996) , inhibited the slowly inactivating K ϩ current of small DRG neurons, indicating that Kv1.1 channels contribute to the delayed rectifier current in these cells. The mechanism of BAB inhibition was further investigated by examining its effect on Kv1.1 channels expressed in mammalian cells. BAB produces a concentration-dependent inhibition of the heterologously expressed Kv1.1 that is comparable to that observed for the native DRG K ϩ current. The data suggest that BAB inhibition of DRG Kv1.1 channels may contribute to the long-duration anesthesia produced by the epidural administration by this drug.
Materials and Methods
Neonatal mice were sacrificed by decapitation in accordance with the standards of the Animal Ethical Committee of Leiden University Medical Center. The DRG from all accessible levels of the spinal cord were collected and mechanically dissociated on a glass coverslip coated with poly-L-lysine (mol.wt. 70,000 -150,000; Sigma-Aldrich, St. Louis, MO) in 0.5 ml of F-12 Ham Kaighn's modified media supplemented with 0.15 g/l CaCl 2 , 0.29 g/l glutamine, 2.5 g/l NaHCO 3 , 7.0 g/l glucose, and 10% horse serum (Invitrogen, Carlsbad, CA). The ganglia cells were allowed to attach to the coated glass coverslips for 2.5 h in a humidified 5% CO 2 atmosphere at 37°C after which an additional 2 ml of F-12 medium was added. The cells were cultured for 3 to 8 h before selecting small (ϳ20-m) spherical neurons devoid of neurite outgrowth for patch-clamp experiments.
The cDNAs of the human Kv1.1 potassium channel and the Kv␤1 subunit (Rettig et al., 1994) were subcloned into pcDNA3.1(Ϫ) (Invitrogen). The cDNA for eGFP (BD Biosciences Clontech, Palo Alto, CA) was subcloned into pcDNA3.1(ϩ) vectors (Invitrogen). tsA201 cells were cotransfected with cDNA encoding Kv1.1 and cDNA encoding for GFP, a green fluorescent marker that facilitates the identification of transfected cells, in a 1:1 ratio. The Kv1.1/GFP cDNA mixture was added to 0.5 ml of DMEM (Sigma-Aldrich) enriched with 10% fetal bovine serum (Invitrogen) and 1% penicillin-streptomycin (Sigma-Aldrich). N- [1] [2] propyl]-N,N,N-trimethylammonium methylsulfate (25 l; Roche Diagnostics, Mannheim, Germany) was slowly added and incubated for 15 min at room temperature. The cDNA/N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate mix was transferred to a 100-mm culture dish of 50% confluent tsA201 cells bathed in 10 ml of enriched DMEM. After 3 h, the transfection solution was removed and replaced with 20 ml of enriched DMEM. After 24 h, the cells were replated on glass coverslips. The cells were incubated an additional 12 to 24 h before selecting GFP-positive cells (excitation: 488 nm, emission 507 nm) for use in patch-clamp studies. For experiments with the Kv␤1 subunit tsA201 cells were cotransfected with Kv1.1, GFP, and Kv␤1 in a 1:1:2 ratio.
For the patch-clamp experiments, a coverslip was mounted in a small perfusion chamber (75 l) and continuously perfused (ϳ300 l/min) with extracellular solution. Patch pipettes were fabricated from borosilicate glass (Clark GC-150 TF-15) on a custom two-stage horizontal puller and had resistances between 1 and 2 M⍀. For DRG neurons the external solution consisted of 35 mM NaCl, 5 mM KCl, 3 mM MgCl 2 , 10 mM HEPES, and 180 mM sucrose, pH 7.35 (NaOH) with 300 nM tetrodotoxin (Sigma-Aldrich). The pipette solution was 20 mM NaCl, 118 mM KCl, 5 mM EGTA, 10 mM HEPES, and 2 mM MgATP, pH 7.35 (NaOH). In experiments with tsA201 cells, the extracellular solution consisted of 136 mM NaCl, 2 mM KCl, 1.5 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM HEPES, pH 7.4 (NaOH). The pipette solution was 115 mM KCl, 1 mM MgCl 2 , 10 mM EGTA, and 10 mM HEPES, pH 7.4 (KOH). BAB was added to the extracellular solution from a stock of BAB in ethanol (1-500 M). The final ethanol concentration in the extracellular solution was in all cases, including control experiments, 0.1%. Dendrotoxin-K (Alomone Labs, Jerusalem, Israel) was dissolved in distilled water before dilution in extracellular solution to a final concentration of 10 nM. Voltage pulses were generated by pClamp 8 (Axon Instruments, Inc., Foster City, CA) and recorded using a List EPC 7 patch-clamp amplifier (List Medical, Darmstadt, Germany). The series resistance of the patch pipettes was 75% compensated and current recordings were filtered at 3 kHz. All currents were leak subtracted using P/4 subtraction. Membrane capacitance of the cells was estimated from the decay of the transient elicited by a 10-mV depolarizing voltage pulse from a Ϫ80-mV holding potential.
The concentration-inhibition data were fitted to the Hill equation:
, where the IC 50 value is the concentration at which the current is reduced by 50% and n is the Hill coefficient. The activation data obtained from tail current measurements (Fig. 4) were fitted to the Boltzmann equation:
, where V is the prepulse potential, V 0.5 the voltage at which the current is half-maximally activated, and k is the slope factor. Unless otherwise stated, the data are the means Ϯ S.D. for a given number (n) of cells.
Results

BAB Inhibition of the Endogenous K
؉ Current of DRG Neurons. To investigate the role of K ϩ channels in the BAB anesthesia, we used the patch-clamp technique to measure the whole-cell K ϩ current of small cultured DRG neurons (Ϸ20 m, 14 Ϯ 3 pF, n ϭ 49), which are believed to represent the cell bodies of nociceptive pain fibers. The outward K ϩ currents were isolated by blocking sodium currents with tetrodotoxin (300 nM) and by applying test pulses close to the sodium reversal potential to minimize the contribution of the remaining TTX-resistant current. Calcium currents and calcium-activated currents were eliminated by removing external calcium and by including EGTA in the patch pipette. Cells were held at Ϫ80 mV and currents were elicited by depolarizing steps to ϩ20 mV (Fig. 1A) . The majority of the K ϩ current in these cells seems to be best classified as the slowly inactivating or noninactivating variety. Only a relatively minor contribution of the rapidly inactivating I A component was observed in our study. Bath application of BAB (200 M) reduced the amplitude of the current (Fig. 1A) . BAB inhibited the whole-cell K ϩ current of the small DRG neurons in a concentration-dependent manner with an IC 50 value of 223 Ϯ 10 M (Fig. 1B) .
Kv1.1 Channels Contribute to the Delayed Rectifier Current of DRG Neurons. At least four distinct components have been shown to contribute to the slowly inactivating and sustained K ϩ current of DRG neurons but the molecular identities of the underlying channels have not been established (Safronov et al., 1996) . Previous studies have shown that small DRG neurons express a slowly inactivating dendrotoxin-sensitive K ϩ current, suggesting that members of the Kv1 family may contribute to the delayed rectifier current in these cells (Penner et al., 1986; Stansfeld et al., 1986 Stansfeld et al., , 1987 Hall et al., 1994; McAlexander and Undem, 2000; Glazebrook et al., 2002) . To further investigate the channels underlying the slowly inactivating K ϩ current, we applied DTX K , a specific inhibitor of Kv1.1 channels (Robertson et al., 1996) . DTX K (10 nM) decreased the whole-cell K ϩ current of DRG neurons by 34 Ϯ 7% (n ϭ 7) ( Fig. 2A) . The DTX Ksensitive component of the DRG current was isolated by subtracting the current remaining after application of DTX K from the total K ϩ current (Fig. 2B ). The DTX K -sensitive component rapidly activated and displayed little inactivation during the 250-ms depolarization. The high sensitivity to DTX K indicates that Kv1.1 channels, or heteromultimeric channels incorporating the Kv1.1 subunit, contribute to the slowly inactivating K ϩ current in these neurons. We attempted to gain additional insight into the mechanism of BAB inhibition by investigating the overlap of the BAB-and DTX K -sensitive components of the native DRG K ϩ current. In the absence of BAB, DTX K (10 nM) inhibited 34% of the DRG current. This contrasts with what is observed in presence of 200 M BAB (Fig. 2, C and D) , which significantly (p ϭ 0.001) reduced the relative amplitude of the DTX K -sensitive current (20 Ϯ 5%, n ϭ 6). This suggests that the toxin and BAB inhibit a common component of the DRG K ϩ current. The relative amplitude of the DTX K -sensitive current was further reduced by preapplying 500 M BAB (9 Ϯ 4%, n ϭ 6, p ϭ 1 ϫ 10 Ϫ5 ), providing additional support for inhibition of DTX K -sensitive current by BAB. The high selectivity of DTX K indicates that the reduction in the amplitude of the native DRG K ϩ current, at least in part, results from the inhibition of Kv1.1 channels. In many cases, high concentrations of BAB (500 M) completely inhibited the DRG K ϩ current, suggesting that in addition to Kv1.1, other delayed rectifier currents were inhibited at these concentrations.
BAB Inhibition of Heterologously Expressed Kv1.1 Channels. To further investigate the mechanism of BAB inhibition, the cDNA encoding for Kv1.1 was heterologously expressed in tsA201 cells. At ϩ20 mV, the Kv1.1 channels rapidly activated but only slowly inactivated similar to the DTX K -sensitive component of DRG K ϩ current (Fig. 3A) . Fig. 1 . BAB inhibition of the native K ϩ current of small DRG neurons. A, whole-cell patch-clamp recording of K ϩ current from an acutely dissociated DRG neuron. Currents were elicited by depolarizing to ϩ20 mV from a holding potential of Ϫ80 mV. Current recorded from the same cell is shown before and after the bath application of 200 M BAB. B, currents measured in the presence of BAB were normalized to drug-free controls and plotted versus the concentration. The smooth curve is a fit to the Hill equation
with an IC 50 value of 223 Ϯ 10 M and Hill coefficient of 1.7 Ϯ 0.1 (n ϭ 32).
Fig. 2. Inhibition of K
ϩ current in a DRG neuron by DTX K . A, K ϩ current elicited by depolarizing to ϩ20 mV from a holding potential of Ϫ80 mV. Currents are shown before and after the bath application of 10 nM DTX K . Currents were reduced 34 Ϯ 7% by comparison to controls (n ϭ 7). B, DTX K -sensitive component of the DRG current (a-b) was isolated by subtracting the residual current remaining after application of DTX K from the total DRG current in A. C, K ϩ current elicited by depolarizing to ϩ20 mV from a holding potential of Ϫ80 mV. Currents are shown in control conditions, and after the sequential application of 200 M BAB and 10 nM DTX K ϩ 200 M BAB. D, DTX K -sensitive component as obtained by subtracting the current measured in the presence of BAB ϩ DTX K from the current measured in the presence of 200 M BAB alone (b-c). Calibration bars in A apply to all panels. Fig. 3 . BAB inhibition of homotetrameric Kv1.1 channels. A, Kv1.1 channel was heterologously expressed in tsA201 cells and currents were recorded by depolarizing to ϩ20 mV from a holding potential of Ϫ80 mV. BAB (10 -500 M) progressively inhibits the whole-cell K ϩ current of the Kv1.1 channels. B, current measured in the presence of BAB was normalized to drug-free control currents and plotted versus concentration. The smooth curve is a fit to the Hill equation with IC 50 value and Hill coefficient of 238 Ϯ 10 M and 1.8 Ϯ 0.1, respectively. The data are means Ϯ S.D. of eight to nine determinations at each concentration.
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at ASPET Journals on November 7, 2016 jpet.aspetjournals.org BAB inhibited the homomultimeric Kv1.1 channels in a concentration-dependent manner with an IC 50 value of 238 Ϯ 10 M (Fig. 3B) , similar to what is observed for the native DRG current. In addition to reducing the amplitude, BAB caused the current to decay more rapidly. In the absence of drug, the current decay could be well fitted by a single exponential with a time constant of 373 Ϯ 47 ms and a relative amplitude of 0.26 Ϯ 0.02 (n ϭ 4). This is likely to reflect the slow inactivation of Kv1.1 channels. After application of 200 M BAB, the peak current was reduced by 53 Ϯ 2% and the decay time course was found to be biexponential with time constants (relative amplitudes) of 36 Ϯ 2 ms (0.11 Ϯ 0.02) and 301 Ϯ 56 ms (0.35 Ϯ 0.01), respectively (n ϭ 4). BAB induced a new rapid component of current decay and increased the relative amplitude of the slow component by comparison to drug-free controls. The data suggest that BAB may enhance the slow inactivation of Kv1.1. However, the onset of this component is too slow to account for the large reduction in the peak amplitude of the current. Other mechanisms that have faster kinetics or that reduce the probability that a channel will open, are likely to play a more prominent role in the BAB inhibition of these channels.
We also examined the effect of BAB on the reversal potential and activation gating of the Kv1.1 channels. For voltages between Ϫ80 and 0 mV the instantaneous current amplitudes were determined from the peak of the tail currents (Fig. 4A ), which were normalized and plotted versus the voltage (Fig. 4B) . Over this range of voltages, the currentvoltage relationship is linear with an extrapolated reversal potential of Ϫ89 Ϯ 7 mV. Also plotted is the current-voltage relationship determined after the application of 200 M BAB, which has a reversal potential of Ϫ91 Ϯ 11 mV. Although the peak current amplitudes are reduced, the reversal potentials are not significantly different, indicating that BAB does not alter the selectivity of Kv1.1 channels (paired t test, n ϭ 8).
The effect of BAB on the activation of Kv1.1 was investigated by plotting the normalized peak amplitudes of the tail currents versus the prepulse potential (Fig. 4C) . In the absence of drug, the normalized current-voltage relationship was fitted to a Boltzmann function with a V 0.5 and k of Ϫ35 Ϯ 3 and 4.6 Ϯ 1.0 mV, respectively (n ϭ 8). BAB (200 M) reduced the tail current amplitudes but did not alter the midpoint of steady-state activation (V 0.5 ϭ Ϫ34 Ϯ 3 mV). These effects were completely reversed upon removing BAB from the bath. The data indicate that in the presence of BAB, Kv1.1 channels display a reduced open probability or unitary conductance relative to the drug-free controls that cannot be attributed to a change in the voltage dependence of channel activation or selectivity. BAB may inhibit the Kv1.1 current through changes in the kinetics of gating or a reduction in the channel conductance.
BAB Accelerates the Activation and Deactivation of Kv1.1 Channels. Fig. 5 shows Kv1.1 current measured at Ϫ30 mV before and immediately after the bath application of 200 M BAB. The currents have been normalized to facilitate the comparison of the kinetics. BAB accelerates both the activation and deactivation time course of the current. To quantitatively compare the activation, we determined the time required for the current to reach its half-maximal amplitude. In eight paired experiments the half-maximal rise times were 10.7 Ϯ 1.7 and 6.0 Ϯ 1.0 ms before and after application of 200 M BAB, respectively. BAB significantly accelerates the rising phase of the current (paired t test, p Ͻ 0.001), an effect that cannot be attributed to a shift in the voltage dependence of activation (Fig. 4B) . We also examined the effect of BAB on the kinetics of activation at ϩ20 mV, a voltage where the channels are maximally activated. At ϩ20 mV, the time to half of maximum amplitude was 2.6 Ϯ 0.4 ms for controls and 2.4 Ϯ 0.4 ms after application of BAB (n ϭ 9). In the absence of drug, the half-maximal rise times at ϩ20 mV were reduced by comparison with those measured at Ϫ30 mV and are consistent with the strong voltage dependence of Kv1.1 activation. Although the relative difference in the rise times of the control and drug-treated current at ϩ20 mV is small, it was found to be significant in a paired t test (p Ͻ 0.002). This indicates that the more rapid rise of the current observed after application of BAB results from a genuine increase in the activation kinetics and does not reflect contamination by deactivation, which is likely to contribute to the apparent activation kinetics at the less depolarized (Ϫ30-mV) test potential.
In addition to its effects on activation, BAB also enhances the deactivation of Kv1.1. Figure 6A shows a family of normalized Kv1.1 tail currents measured before and after application of BAB (50 -250 M). BAB accelerates the deactivation of the channels in a concentration-dependent manner Fig. 4 . Effect of BAB on reversal potential and Kv1.1 activation. A, currents were activated by stepping for 50 ms to 0 mV before applying a series of 200-ms test pulses to voltages between Ϫ80 and 0 mV followed by a step to Ϫ50 mV before returning to the holding potential. B, currentvoltage relationship was determined by measuring the peak amplitudes of the tails elicited by the variable voltage pulses. The currents were normalized to the current measured at 0 mV and plotted versus the voltage. The data are the means Ϯ S.D. for eight individual experiments. C, activation was determined by plotting the normalized peak currents elicited by the Ϫ50 mV tail currents versus the prepulse voltage. The smooth curves are fits to a Boltzmann function with midpoints and slope factors of Ϫ35 Ϯ 3 and 4.6 Ϯ 1.0 mV for controls and Ϫ34 Ϯ 3 and 7.0 Ϯ 1.3 mV after application of 200 M BAB (n ϭ 8). ( Fig. 6B) . Also shown are two typical tail currents of DRG neurons in the absence and presence of 200 M BAB (Fig.  6C) . The tail currents are well fitted by a single exponential with time constants () of 17.0 Ϯ 5.9 ms (n ϭ 8) in the absence and 4.0 Ϯ 1.4 ms (n ϭ 9) in the presence of BAB. BAB produces a similar increase in the deactivation of both the heterologously expressed Kv1.1 and the native DRG K current. Overall, the data indicate that changes in both activation and deactivation kinetics may contribute to the BAB inhibition of Kv1.1 channels.
Effect of the Kv␤ Subunit on the Gating and BAB Sensitivity of Kv1.1. Previous studies have shown that coexpressing Kv1.1 and Kv␤ subunits result in a rapidly inactivating A-type current. The N terminus of the Kv␤1 subunit is proposed to act as an inactivation particle that occludes the internal vestibule of activated Kv1.1 channels (Rettig et al., 1994) . We were therefore interested in determining the effects of the Kv␤1 subunit and rapid inactivation on the BAB sensitivity of Kv1.1 channels. Coexpressing the Kv␤1 and Kv1.1 subunits resulted in current that rapidly inactivated similar to what has been previously reported for this oligomeric channel (Fig. 7A) . Similar to the Kv1.1 channels, BAB inhibited the Kv1.1/Kv␤1 channel in a concentration-dependent inhibition manner. The peak currents measured before and after application of BAB were normalized to drug-free controls and plotted versus the BAB concentration (Fig. 7B) . BAB inhibited the current with an IC 50 value and Hill coefficient of 343 Ϯ 10 M and 2.1 Ϯ 0.2, respectively (n ϭ 17). The BAB sensitivity of Kv1.1 (IC 50 ϭ 238 M) was significantly reduced by coexpressing the channel with the Kv␤1 subunit. It is not clear whether the reduced inhibition results from a conformational change in Kv1.1 induced by the Kv␤1 subunit or whether rapid inactivation somehow weakens BAB binding.
To further investigate the role of inactivation in the BAB inhibition we examined its effects on the steady-state inactivation of the Kv1.1/Kv␤1 channel. Depolarizing prepulses were used to inactivate the channels before applying a standard test pulse to assay availability (Fig. 7C, inset) . The currents elicited by the test pulses were normalized to controls measured after prolonged hyperpolarization to Ϫ80 mV and plotted versus the prepulse voltage. The relative amplitudes of the test currents progressively decrease with prepulse voltage consistent with an increase in steady-state inactivation. The smooth curves are fits to the Boltzmann function with a V 0.5 and k of Ϫ53 Ϯ 3 and 3.4 Ϯ 0.2 mV, respectively (n ϭ 4). BAB (200 M) reduces the maximal current amplitude measured at hyperpolarized voltages by 12% but does not significantly alter the midpoint (V 0.5 ϭ Ϫ56 Ϯ 2 mV) or voltage sensitivity (k ϭ 4.8 Ϯ 0.7 mV) of inactivation. Hyperpolarizing shifts in steady-state inactivation are typical of drugs that preferentially affect channel inactivation. BAB does not inhibit the Kv1.1/Kv␤1 by preferentially interacting with the inactivated state of the channel. Furthermore, the BAB inhibition persists at hyperpolarized voltages (Ϫ80 mV) where few of the Kv1.1/Kv␤1 channels are predicted to be inactivated. Overall, the data suggest that rapid inactivation does not play a prominent role in the BAB inhibition of Kv1.1. Conformational changes Fig. 6 . BAB accelerates the deactivation of Kv1.1 channels. A, potassium currents evoked by a step to ϩ20 mV for 50 ms and the tail currents measured upon return to Ϫ65 mV. The superimposed tail currents are shown before (control) and after the bath application of 50, 150, and 250 M BAB. B, decay of the tail current was fitted with a single exponential and the resulting time constants plotted versus the concentration (n ϭ 7). C, effect of BAB on the DTX K -sensitive tail currents of cultured DRG neurons. The DTX K -sensitive component was obtained by subtracting the current remaining after application of the toxin (10 nM) from the total K ϩ current (Fig. 2) . The current of two cells are shown in the absence (left) and presence (right) of 200 M BAB.
Fig. 7.
BAB effects on Kv1.1 channels coexpressed with the Kv␤1 subunit. A, whole-cell current of cells expressing the Kv1.1␣ and Kv␤1 subunits. Currents were elicited by depolarizing to ϩ20 mV from a holding potential of Ϫ80 mV. Currents are shown before (control) and after bath application of 10, 200, and 500 M BAB. B, peak amplitude of the currents measured in the presence of BAB were normalized to the drug-free controls and plotted versus [BAB] . The smooth curve is a fit to the Hill equation with an IC 50 value of 343 Ϯ 10 M and coefficient of 2.1 Ϯ 0.2. The data are means Ϯ S.D. of seven or eight determinations at each concentration. C, steady-state inactivation was measured by applying 500-ms prepulses to voltages between Ϫ80 and Ϫ20 mV. Only the last 30 ms of the prepulses is shown for clarity. A short hyperpolarization to Ϫ80 mV for 4 ms was used to fully deactivate the channels before applying a standard test pulse to ϩ50 mV. The peak amplitudes of the test currents were normalized to controls measured directly from the Ϫ80-mV holding voltage and plotted versus the prepulse potential. The smooth curves are fits to the Boltzmann function with midpoints and slope factors of Ϫ53 Ϯ 3 and 3.4 Ϯ 0.2 mV for controls (filled circles) and Ϫ56 Ϯ 2 and 4.8 Ϯ 0.7 mV after applying 200 M BAB (open triangles) (n ϭ 4).
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Discussion
In this study, we investigated the anesthetic sensitivity of the slowly inactivating K ϩ current of small cultured DRG neurons of neonatal mice. The majority of the whole-cell K ϩ current of these neurons rapidly activates and slowly inactivates and has properties that are consistent with a delayed rectifier type current. We further investigated the role of Kv1 channels using DTX K , a specific inhibitor of channels incorporating the Kv1.1 subunit (Wang et al., 1999) . DTX K inhibited 34% of the slowly inactivating DRG K ϩ current, consistent with an important contribution of Kv1.1 to the delayed rectifier current in these neurons. This finding is in agreement with a recent study showing that DTX K inhibits the delayed rectifier current of C-type neurons (Glazebrook et al., 2002) . BAB inhibited the slowly inactivating K ϩ current of DRG neurons in a dose-dependent manner with an IC 50 value of 223 M. Our data indicate substantial overlap in the inhibition produced by BAB and DTX K , supporting the conclusion that Kv1.1 channels contribute to the BAB-sensitive current in these small DRG neurons. The inhibition of Kv1.1 channels occurs within the range of BAB concentrations realized in the epidural space during the clinical administration of this drug (Grouls et al., 1997) .
BAB Inhibition of Kv1.1 Channels. To better understand the mechanism, we examined the effects of BAB on the current of heterologously expressed Kv1.1 channels. Kv1.1 rapidly activates and slowly inactivates similar to what is observed for the DTX K -sensitive current of DRG neurons. BAB inhibited Kv1.1 with an IC 50 value of 238 M, which is nearly identical to what was observed for the inhibition of the native DRG K ϩ current (IC 50 value ϭ 223 M). In addition to reducing the current amplitude, BAB accelerated the activation and deactivation kinetics of Kv1.1 but did not produce any change in the midpoint of activation. A similar BABinduced increase in the kinetics of deactivation was observed for the native DRG K ϩ current. Assuming a simple two-state model for activation gating suggests that the opening and closing kinetics are equally enhanced by BAB. Such symmetrical changes in opening/closing rates are difficult to explain by the preferential binding of BAB to either the closed or open conformations of the channel. BAB does not seem to act by a state-dependent binding mechanism.
Several mechanisms could potentially explain the BAB inhibition of Kv1.1 channels. We initially considered that the inhibition produced by BAB could result from a channel blocking mechanism. However, simple blocking models generally predict slower deactivation because the channels often cannot close until the drug dissociates from its binding site (Armstrong, 1971) . This is clearly inconsistent with the observed effects of BAB on either the heterologously expressed Kv1.1 or native DRG tail currents, which were faster in the presence of the drug. BAB also induced a slow decay in the sustained current of heterologously expressed Kv1.1 that may be linked to the slow inactivation of these channels. However, the time course of this decay ( ϭ 36 ms) is too slow to account for the reduction in the amplitude of the peak current observed after the application of BAB. The observed kinetic changes also indicate that a reduction of single channel conductance cannot be the sole mechanism. Rather the data seem to favor an allosteric mechanism in which BAB biases the channels toward the closed state. Rapid deactivation may effectively stabilize the channels in closed (nonconducting) conformations and could account for the BAB-induced reduction in the amplitude of Kv1.1 and native K ϩ current in DRG neurons.
Coexpression of the Kv␤1 subunits confers rapid N-type inactivation on the slowly inactivating Kv1.1 channels (Rettig et al., 1994; Heinemann et al., 1996) and the message encoding for several of the Kv␤ subunits is present in the sensory neurons of nodose ganglion (Glazebrook et al., 2002) . Consistent with these previous findings we found that coexpressing the Kv␤1 subunit resulted in rapid but incomplete inactivation of Kv1.1. This rapid inactivation contrasts with the native DTX K -sensitive component of DRG K ϩ current, which slowly inactivates similar to what is observed when Kv1.1 channels are expressed alone. Our data therefore suggest that the endogenous Kv1.1 channels expressed in DRG neurons may not associate with the Kv␤1 subunit. Alternatively, Kv1.1 subunits may form heteromultimers with other Kv1 subunits (Isacoff et al., 1990; Ruppersberg et al., 1990) , resulting in channels that retain sensitivity to DTX K (Wang et al., 1999) but that are not strongly regulated by the Kv␤ subunit. The rapidly inactivating Kv1.1/Kv␤1 oligomeric channel (IC 50 ϭ 343 M) is considerable less sensitive to BAB than Kv1.1 (IC 50 ϭ 238 M). BAB does not alter the kinetics of the current decay or steady-state inactivation of the Kv1.1/Kv␤1 channels, suggesting that N-type inactivation is not tightly linked to the BAB inhibition. Rather the data suggest that interaction with the Kv␤1 subunit may induce a conformational change in Kv1.1 that weakens BAB binding or that indirectly modulates the inhibitory mechanism.
Role of Kv1.1 Channels in the Long-Duration BAB Anesthesia of DRG Neurons. Voltage-gated K ϩ currents play an integral role in setting the resting membrane potential and in action potential repolarization and are important determinates of spike frequency and burst adaptation (Rudy, 1988) . Small DRG neurons, which are believed to reflect the cell bodies of unmyelinated C-fibers, display Kv1.1 immunoreactivity and the DRG contains RNA encoding for Kv1.1 channels (Beckh and Pongs, 1990; Hallows and Tempel, 1998; Ishikawa et al., 1999) . The importance of Kv1 channels to the electrical excitability of DRG neurons is illustrated by studies showing that DTX ␣ , an inhibitor of several of the Kv1 channels, induces rapid repetitive firing of sensory neurons (Stansfeld et al., 1986; McAlexander and Undem, 2000; Glazebrook et al., 2002) . This is further supported by studies of Kv1.1-null mice, which display hyperalgesia and reduced sensitivity to opiate therapy, symptoms frequently associated with neuropathic pain (Clark and Tempel, 1998) . It suggests that the absence of Kv1.1 in the null mice causes sensory neurons to become hyperexcitable, similar to what is observed after application of DTX. This is consistent with data showing that the delayed rectifier current makes an important contribution to the resting membrane potential of small DRG neurons (Safronov et al., 1996) . Overall, these previous studies seem to be in good agreement of our data indicating that Kv1.1 channels contribute to the delayed rectifier current of DRG neurons. 
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A possibility is that like DTX, BAB inhibition of Kv1.1 may paradoxically increase rather than suppress the electrical excitability of DRG neurons. This might be expected to cause hyperalgesia similar to what was observed in the Kv1.1-null mice (Clark and Tempel, 1998) . However, other effects of BAB should also be taken into account. Previous studies indicate that in addition to K ϩ channels, the endogenous Na ϩ currents of DRG neurons are also sensitive to BAB. At least two Na ϩ channels are known to contribute to the electrical excitability of small DRG neurons. Nav1.7 is a rapidly gating TTX-sensitive Na ϩ channel and Nav1.8 is a slowly gating TTX-resistant Na ϩ channel . Although both channels are generally believed to contribute to the Na ϩ current of sensory neurons, Nav1.8 seems to be exclusively expressed in the cell bodies of C-fibers (Akopian et al., 1996; Sangameswaran et al., 1996) . Recent work has demonstrated that low-frequency repetitive stimulation (1-2 Hz) significantly reduces the steady-state availability of the Nav1.8 channels, an effect that seems to be due to the unusually rapid onset of slow inactivation in these channels (Vijayaragavan et al., 2001) . By comparison, Nav1.7 channels are considerably less sensitive to repetitive stimulation and are more resistant to slow inactivation. Similar observations have been made for the native TTX-sensitive and TTXresistant Na ϩ currents of DRG neurons (Rush et al., 1998; Scholz et al., 1998) . BAB causes a hyperpolarizing shift of the steady-state inactivation of the TTX-sensitive Na ϩ currents ( Van den Berg et al., 1995 . This is predicted to reduce the availability of these Na ϩ channels, an effect that would be exacerbated by the inhibition of Kv1.1 and depolarization of the resting membrane potential. Because of the substantial differences in the voltage dependence of the Nav1.7 and Nav1.8 channels, even a slight depolarization of the resting membrane potential would tend to selectively inactivate Nav1.7 and therefore increase the relative amplitude of the slower gating TTX-resistant currents. This could have important implications for the firing behavior of DRG neurons (cf. Vijayaragavan et al., 2001) . Inhibition of Kv1.1 may also delay and weaken the repolarization of DRG neurons after an action potential similar to what has been previously observed with DTX K (Glazebrook et al., 2002) . Delayed repolarization would tend to slow the recovery of inactivated Na ϩ channels and further increase the refractory period for action potential firing.
Our current working hypothesis is that BAB influences the availability of ion channels responsible for maintaining the high electrical excitability of DRG neurons. BAB inhibition of Kv1.1 and peripheral nerve Na ϩ channels may contribute to the long-duration anesthesia associated with the epidural administration of this drug.
